FDA Adverse Event Malfunction Summary report: N

COAGUCHEK ® XS SYSTEM

MDR report key: 3173524 · Received June 17, 2013

Report

Report Number
1823260-2013-03635
Event Type
Malfunction
Date Received
June 17, 2013
Date of Event
May 13, 2013
Report Date
July 24, 2013
Manufacturer
ROCHE DIAGNOSTICS
Product Code
GJS
PMA / PMN Number
K062925
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

IT IS NOT KNOWN IF THE INITIAL REPORTER HAS OR INTENDS TO REPORT THE EVENT TO FDA.

Description of Event or Problem · 1

REPORTER STATED THAT A HOME HEALTH NURSE TESTED A PATIENT CAPILLARY SAMPLE ON THE COAGUCHEK XS SYSTEM AND OBTAINED A RESULT OF 6.8 INR. WITHIN 4 HOURS, A VENOUS SAMPLE OBTAINED FROM THE SAME PATIENT, REPORTEDLY MEASURED 4.5 INR ON AN UNSPECIFIED LABORATORY INSTRUMENT. BASED ON THE LABORATORY RESULT, PATIENT'S PHYSICIAN WITHHELD COUMADIN DOSE. NO ADVERSE EVENT ASSOCIATED WITH THE ALLEGED MALFUNCTION WAS REPORTED. THE MANUFACTURER REQUESTED THE RETURN OF THE SUSPECT PRODUCT FOR EVALUATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
272924 COAGUCHEK ® XS SYSTEM PROTHROMBIN TIME TEST STRIPS GJS ROCHE DIAGNOSTICS NA 21512412

Patients

Seq Age Sex Outcome Treatment
1 065 YR B COMPLEX VITAMIN| FOSAMAX| BENICAR HCT| NICOTINE, TOPICAL| HYDROCODONE| ATORVASTATIN| DIAZEPAM| CYANOCOBALAMIN| CALCIUM CARBONATE| ADVAIR INHALER| ALBUTEROL INHALER| WARFARIN| DILITIAZAM| VITAMIN D3| LORATADINE| DULOXETINE| FISH OIL| DIVALPROEX